Loading clinical trials...

Additional Post Hoc Analysis and Clinical Data Collection | Clinical Trials | Clareo Health

COMPLETEDNCT02860416

Additional Post Hoc Analysis and Clinical Data Collection

The purpose of this study is to collect additional Investigational cognitive tasks and additional clinical data for subjects tested with ElMindA's Brain Network Activation (BNA™).

Lead sponsor: ElMindA Ltd•2 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Related studies

COMPLETED

Facioscapulohumeral Dystrophy in Children

NCT02625662 · Neurological Observations, Facioscapulohumeral Muscular Dystrophy, and more

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: June 6, 2019Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment55

Start dateJul 2016

Last updatedJun 6, 2019

Condition

Neurological Observations

Locations shown

ElMindA

Glenview, Illinois

Premier Psychiatric Group

Lincoln, Nebraska

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: June 6, 2019Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions